and how they are affecting the patterns of natural variation between species." Barry E. DiGregorio is a freelance writer in Middleport, N.Y.
Utrecht University, the Netherlands, who was not involved in the research. "The results suggest that the rhizosphere microbiome comes to the rescue when wheat is attacked by pathogens."
Pseudomonads producing the antibiotic phenzaine-1-carboxylic acid (PCA) are abundant in the rhizosphere associated with dryland wheat, enabling these root-colonizing bacteria to suppress the pathogen Rhizoctonia, which can cause root rot, according to Weller and his collaborators. However, those PCA-producing pseudomonads are only rarely found colonizing the roots of wheat plants that are planted where annual precipitation levels are higher. This major dryland wheat-growing area of Washington, in the rain shadow of the Cascade Range, is lucky to receive 11 inches of precipitation per year.
However, parts of this fertile region are intensively irrigated, and the consequent higher moisture in farmland soils shifts the microbial community that associates with the roots of irrigated wheat plants, according to Weller and Linda Thomashow, also at ARS, and their collaborators Olga and Dmitri Mavrodi at nearby Washington State University. Remarkably, the pseudomonads found in these irrigated soils produce the antibiotic 2,4-diacetylphloroglucinol instead of PCA. "This shift in bacterial antagonists with irrigation coincides with the shift in diseases that these antagonists are known to control," Thomashow says. Nonoverlapping Pseudomonas fluorescens strains-possibly separate species-produce those two different antibiotics, she adds.
Despite these and perhaps other natural antibiotics being produced along the roots of wheat plants, root diseases cause "billions of dollars in losses in wheat production in the U.S. and worldwide, annually," Weller says.
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System in Cells of
C. elegans Detects, Responds to Pathogens
Cells of the roundworm Caenorhabditis elegans carry a newly recognized system for responding to pathogens and toxins, according to Gary Ruvkun and Frederick Ausubel, both of Massachusetts General Hospital in Boston, and Emily Troemel of the University of California, San Diego, and their respective collaborators. When particular bacterial pathogens are present, protein synthesis is blocked in the roundworm cells while the expression of various defense genes is elevated. Altogether, the system enables the roundworm to discriminate between pathogens and harmless bacteria. "Viewing many diseases through the prism of this newly discovered system will eventually allow a reinterpretation of disorders from several branches of medicine as aberrant responses to toxins and bacteria," Ruvkun says. Taking revised claims about modifıed H5N1 influenza viruses into account, the members of the U.S. National Science Advisory Board for Biosecurity (NSABB) last March reversed their earlier unanimous recommendations and called for publishing two revised reports describing that research (Microbe, May 2012, p. 214). However, that reversal provoked a pointed protest from NSABB member Michael Osterholm of the University of Minnesota, Minneapolis, and did not quell the broader debate about how to handle this or other cases involving dual-use research of concern (DURC). Also in March, U.S. offıcials issued a policy statement mandating federal agencies to review federally funded projects entailing potential DURC and to develop plans for dealing with them.
Some of the broader discussion of these issues continued in April under the auspices of the Royal Society through its symposium "H5N1 Research: Biosafety, Biosecurity and Bioethics," held in London, England, and sponsored in part by ASM. Yet other chapters in this ongoing debate are anticipated, including a hearing last April before the Senate Committee on Homeland Security and Governmental Affairs.
In deliberations late in 2011, NSABB members favored redacting details and postponing publication of research on the H5N1 flu virus by Ron Fouchier of the Erasmus Medical Center in the Netherlands, Yoshihiro Kawaoka of the University of Wisconsin, Madison, and their respective collaborators. In March, the group unanimously supported full publication of the Kawaoka fındings, according to NSABB acting chair Paul Keim, who is from Northern Arizona University in Flagstaff. One practical reason to revert to full publication is that no one yet has devised an acceptable plan for circulating H5N1 data on a restricted basis, and the development of such a system is likely several years away, he says.
In a split 12-to-6 vote, NSABB members recommended publishing "the data, methods, and conclusions" in the revised manuscript from Fouchier "after appropriate further scientifıc review and revision," according to a statement from Francis Collins, Director of the National Institutes of Health. A fınal recommendation regarding the two revised manuscripts "will be made by the Health and Human Services Secretary and brought to the broader U.S. government."
However, in his detailed April 12 letter to NIH offıcials that was shared with other board members but then circulated more widely, NSABB member Osterholm criticizes the board's latest review of the H5N1 research, arguing that the process was "one-sided" and the outcome preordained. Along with concerns about the review process, he points to specifıc concerns about a mutation in the virus recently identifıed by Fouchier and his collaborators that "confers H5N1 transmissibility between mammals without ferret passage."
Calling any forthcoming report of that fınding "a pretty complete cookbook" that could make it easy for others to misuse, Osterholm complains that "the current NSABB action just
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Antimicrobial Drugs and Comparable Strategies: Recent Developments
Recent developments affecting antimicrobial drugs include:
• Several newly identified, low- 
